“The surveyed neoplasms were glioblastoma, lung, cholangiocellular and pancreatic carcinomas, metastasized sarcoma, and renal cell carcinoma. Median overall survival was compared to expert expectations of survival outcomes by specific cancer type and was prolonged across observed cancer entities (p<0.001).”
If you liked the information on this page you may also enjoy our regular newsletter, full of information, news, discounts, and offers. Subscribe here.
Comments are moderated and may take up to 24 hours to appear.
No comments yet.
Sorry, the comment form is closed at this time.